A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma
Status:
Recruiting
Trial end date:
2022-07-01
Target enrollment:
Participant gender:
Summary
This study seeks to estimate the occurrence of adverse events related to the study treatment
(Cryosurgical freezing and Intratumoral Combination Immunotherapy), as well as determine the
potential efficacy.